Stephanie Atcher Weaver is a distinguished healthcare and pharmaceutical professional with an impressive 29-year career marked by exceptional leadership, scientific expertise, and a strong track record of success across multiple therapeutic areas. With specialties spanning rare diseases, sleep medicine, pulmonology, neurology, nephrology, hematology/oncology, cardiovascular disease, cholesterol metabolism, and diabetes, she has developed a reputation as a trusted leader and innovator in the healthcare sector.
Throughout her career, Stephanie has demonstrated unparalleled expertise in working with cross-functional teams, collaborating closely with marketing departments, managing large-scale projects, and driving key customer-focused initiatives. She has consistently excelled in strategic leadership roles, fostering relationships with key opinion leaders (KOLs), spearheading formulary wins at major institutions, and achieving significant sales milestones. Her deep scientific acumen is complemented by her business-savvy approach, which has enabled her to thrive in competitive markets and high-stakes environments.
Stephanie is a Pinnacle Club award winner for 2023 and a Founders Club recipient, recognizing her as one of the top performers in her field. Her tenure at Avadel Pharmaceuticals has been marked by her leadership as a Territory Business Manager, where she was named one of the top 8 in the country for her performance. Earlier, she was honored with the Vice-President Club Award from Merck & Co. for exemplary execution of her role in 2013, ranking in the top 5% nationally.
Her career has taken her through prominent roles in sales and account management, with major pharmaceutical companies such as Novartis, Alnylam Pharmaceuticals, Alexion Pharmaceuticals, Regeneron Pharmaceuticals, and Merck & Co. In these positions, Stephanie has launched and managed several cutting-edge therapies, developed advocacy strategies, and worked with clinicians to drive patient outcomes. For instance, she was instrumental in the successful launch of Givlaari during the pandemic and in establishing key relationships with KOLs in both hematology and nephrology while at Alexion Pharmaceuticals.
Stephanie’s leadership in healthcare extends beyond sales and marketing. She has led national initiatives, collaborated with C-suite executives at healthcare organizations, and made significant contributions to product development and market access strategies. Her ability to engage with diverse stakeholders—from healthcare professionals to institutional leaders—has been a critical factor in her ongoing success.
A graduate of the University of Kentucky with an MBA and a degree in Health Care Administration, Stephanie has always been dedicated to learning and professional growth. She is Lean Six Sigma Green Belt certified and holds additional certifications in cardiovascular care and clinical lipidology. Her commitment to excellence has earned her numerous accolades, including several Regional Awards and special recognitions for her leadership in various pharmaceutical launches.
In addition to her professional endeavors, Stephanie was a previous member of the National Lipid Association, further demonstrating her dedication to advancing healthcare and pharmaceutical research. As a result of her sustained excellence in performance, project leadership, and KOL advocacy, Stephanie Atcher Weaver stands as a highly respected figure in the pharmaceutical industry, committed to improving patient outcomes through innovation and strategic collaboration. Stephanie is deeply passionate about supporting Veterans Affairs and advancing research to find cures for Multiple Sclerosis and Dementia. She is also a dedicated advocate for seniors, focusing on the unique challenges faced by adult children caring for aging parents. Her commitment to these causes reflects her dedication to fostering health, dignity, and well-being for individuals and families navigating complex care needs.
Character: Stephanie Atcher Weaver is a highly respected healthcare professional known for her integrity, strong leadership, and dedication to improving patient outcomes.
Knowledge: She possesses extensive expertise across multiple therapeutic areas, including rare diseases, sleep medicine, and cardiovascular health, backed by nearly three decades of experience.
Strategic: With a proven track record of successful product launches, formulary wins, and KOL advocacy, Stephanie excels in driving customer-focused projects and business growth.
Communication: Her exceptional interpersonal skills allow her to collaborate effectively with cross-functional teams, C-suite executives, and healthcare professionals to foster impactful relationships and drive results.